Overview

Tech Summary

Promoter Holding

Posts

SUNPHARMA

10123456789,001234567895012345678910123456789.7012345678900123456789
+8.30 (+0.80%)
The current prices are delayed.Login/Sign Up to see live prices.
Previous Close: 1043.4
1D
5D
1M
3M
1Y
5Y
Today's low
1040.2
Today's high
1072.15
52 week low
733.7
52 week high
1072.15
Volume
3320916
About
Tech Summary
DMA(12)
₹1028.68
DMA(50)
₹988.87
DMA(100)
₹939.14
DMA(200)
₹907.73
Fund Summary
Market Cap
₹252334.38 Cr.
Enterprise Value
₹249757.45 Cr.
No. of Shares
239.93
P/E
77.1
RoE
4.98
Debt/Equity
0.08
Valuations
PE Chart
100200300400500
PB Chart
4.04.24.44.64.85.05.2
Promoter Holdings
Public : 11.06%
FII : 14.44%
DII : 20.02%
Promoter : 54.48%
Others : 0%
Charts
Debt/Equity
0.100.150.200.25
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
ROE vs ROCE
5.06.07.08.09.010.011.0
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
ROE
ROCE
Revenue vs Profitability (1000Cr.)
5101520253035
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
Revenue
Profit
Margins(%)
1015202530
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
Net Margin
Gross Margin
About
Hero Img
Create your account on Frontpage
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Price Target Potential
Brokerage
Nirmal Bang
Target
1090
Potential
20.82%
Stock Sentiments
88% Bullish
12% Bearish
114 live trades of Rs. 8,617,363.2
M
mohammad-ByMzqf9-s
 
Reputation: 16 • 
Just now
SUNPHARMA FEB23 1050 CE
700 Qty (S) Trade entered
9
903431
 
Reputation: 0 • 
Just now
SUNPHARMA
800 Qty (B) Trade exited
Posts by FrontPage Users
NewsBot-display-image
Reputation: 29,839  •  Just now
Sun Pharma acquires three anti-inflammation brands from Aksigen
Sun Pharma acquires three anti-inflammation brands from Aksigen
The company has acquired Disperzyme, Disperzyme-CD and Phlogam as part of the deal.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Just now
Sun Pharma acquires 3 brands to strengthen anti-inflammatory portfolio
Sun Pharma acquires 3 brands to strengthen anti-inflammatory portfolio
Acquired from Aksigen Hospital, Disperzyme, Disperzyme-CD and Phlogam have been approved by the Drugs Controller General of India for post-operative inflammation in patients undergoing minor surgery and dental procedures
Moneycontrol
Like
Comment
Share
Add a comment
Dhananjay-display-image
Reputation: 3,372  •  Just now

15min chart

SIMPLE PRICE ACTION😎
KEEP THIS IN YOUR WATCHLIST👍

👉NOTE👈
This is only for educational purpose, Do your own analysis before investing.👍👍
Chartbusters - chart - 25713486
Like
Comment
Share
Add a comment
B
Reputation: 212  •  Today 3:44 PM

#technical analysis done
#target hit, now cmp 1062
Chartbusters - chart - 25595540
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Today 11:56 AM
A break of 17,450 could take Nifty down to 17,230
A break of 17,450 could take Nifty down to 17,230
​Nifty has broken down from its consolidation range and slipped below its 100-day exponential moving average (EMA) of 17,900 levels, which was being defended for the past 23 sessions. The short-term moving averages are in a falling mode, which indicates the bearish momentum could continue in the upcoming week.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Jan 27 3:46 PM
Buy Sun Pharmaceutical Industries, target price Rs 1225:  ICICI Direct
Buy Sun Pharmaceutical Industries, target price Rs 1225: ICICI Direct
Higher contribution from specialty and strong domestic franchise is likely to change the product mix towards more remunerative businesses by FY23.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Jan 25 8:18 PM
Sun Pharmaceutical launches phenobarbital sodium injection in US
Sun Pharmaceutical launches phenobarbital sodium injection in US
SEZABY is the first and only product approved by the US Food and Drug Administration (USFDA) for the treatment of neonatal seizures in term and preterm infants, Sun Pharma said in a regulatory filing.
Moneycontrol
Like
Comment
Share
Add a comment
Daily Trade Byte-display-image
Reputation: 1,250  •  Jan 23 5:21 PM

POSITION CALL BUY #SUNPHARMA 1045-48 SL 1000 TG 1120
Chartbusters - chart - 24559709
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Jan 20 8:48 PM
Sun Pharma to get growth boost with addition of Deuroxolitinib to its speciality portfolio: Analysts
Sun Pharma to get growth boost with addition of Deuroxolitinib to its speciality portfolio: Analysts
Brokers remain positive about the acquisition and believe in the growth potential of Deuroxolitinib, which is a part of Concert's patent portfolio
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Jan 20 12:51 AM
Sun Pharma to acquire US-based Concert for $576 million
Sun Pharma to acquire US-based Concert for $576 million
Concert's lead candidate, deuruxolitinib, is being evaluated as a treatment for autoimmune condition alopecia areata, which results in patchy hair loss
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Jan 17 7:53 PM
Sun Pharma Q3 PAT may dip 4% YoY to Rs 19,767 cr: Nirmal Bang
Sun Pharma Q3 PAT may dip 4% YoY to Rs 19,767 cr: Nirmal Bang
Net Sales are expected to increase by 14 percent Y-o-Y (up 2.7 percent Q-o-Q) to Rs 1,12,458 crore, according to Nirmal Bang.
Moneycontrol
Like
Comment
Share
Add a comment
 price action trading-display-image
Reputation: 22,942  •  Jan 17 2:25 AM
2 Likes
Comment
Share
Add a comment
Dhananjay-display-image
Reputation: 3,372  •  Jan 16 4:15 PM


💥Sunpharma daily chart
💥Its on very imp level

SIMPLE PRICE ACTION😎
KEEP THIS IN YOUR WATCHLIST👍

👉NOTE👈
This is only for educational purpose, Do your own analysis before investing.👍👍
Chartbusters - chart - 23301808
1 Like
Comment
Share
Add a comment
 price action trading-display-image
Reputation: 22,942  •  Jan 16 2:57 AM
2 Likes
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Jan 13 7:51 PM
FY24 should see improvement in margins for pharma sector: Aditya Khemka
FY24 should see improvement in margins for pharma sector: Aditya Khemka
However, in FY24 what we believe is that the government will again allow pharma companies to take price increases anywhere in the range of 12% to 13% on the NLEM drugs and the non-NLEM drugs again about up to 10% which will help the price realisation in terms of growth.
The Economic Times
Like
Comment
Share
Add a comment
A
Reputation: 436  •  Jan 12 3:29 PM

My view on Sun Pharma. On a long time frame. #SUNPHARMA
Chartbusters - chart - 22782894
2 Likes
Comment
Share
Add a comment
Financialwavetrader-display-image
Reputation: 2,304  •  Jan 12 3:06 AM

#SUNPHARMA looking good if move above 1040-1050

spurt in volume too

major support around 950-970

looking good for rally above 52 week high
Chartbusters - chart - 22733721
Like
Comment
Share
Add a comment
Dhananjay-display-image
Reputation: 3,372  •  Jan 11 5:08 PM

💥Sunpharma in 1hr chart

SIMPLE PRICE ACTION😎
KEEP THIS IN YOUR WATCHLIST👍

👉NOTE👈
This is only for educational purpose, Do your own analysis before investing.👍👍
Chartbusters - chart - 22606745
19 Likes
Comment
Share
Add a comment
Hardik Mishra-display-image
Reputation: 4,118  •  Jan 11 4:16 PM

Hello everyone
Let's start our morning analysis

#SUNPHARMA Analysis

Facing the resistance 1025 from last week, probability of breakout is high. Keep a close watch in this stock. Buyers are active in pharma sector.

Key levels

1050 & 1070 Is strong resistance

980 & 1000 Is st......read more
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Jan 5 8:16 PM
Nithya Balasubramanian on 2 pharma names to bet on besides Sun & Cipla
Nithya Balasubramanian on 2 pharma names to bet on besides Sun & Cipla
“Coming to the complex generics opportunity, Cipla and Lupin are most exposed. We like Cipla more than Lupin because at least in the near term, there are multiple assets waiting to play out. For Cipla this year, we are hoping to see generic Advair, generic Abraxane which is most likely in the price but beyond that, there will be a generic Qvar, there will be a generic Teriparatide and potentially a generic Flovent as well.”
The Economic Times
Like
Comment
Share
Add a comment
Daily Trade Byte-display-image
Reputation: 1,250  •  Jan 4 3:51 PM
Like
Comment
Share
Add a comment
SureStockLevel-display-image
Reputation: 2,236  •  Jan 4 2:52 AM

#SUNPHARMA buy above 1013 for target of 1020,1030,1040
Chartbusters - chart - 21405171
Like
1 Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Jan 3 2:41 PM
Expect 2023 to be a stable year with a lot of bottom-up opportunities: Rajesh Kothari
Expect 2023 to be a stable year with a lot of bottom-up opportunities: Rajesh Kothari
“2023 was an overall good year. We expect a good stable year and from here, a lot of bottom up opportunities will come up in India across various sectors. If you look at the second quarter of FY23, it is proving that data point. I think there are many bottom up opportunities from here on. It is just the beginning of the growth cycle.”
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Jan 2 4:46 PM
Hot Stocks: Brokerages on Jubilant FoodWorks, Sun Pharma and Federal Bank
Hot Stocks: Brokerages on Jubilant FoodWorks, Sun Pharma and Federal Bank
"The bank has managed asset quality well throughout the epidemic, and the bank intends to aggressively extend its footprint through partnerships with fintech companies as well as physical expansion. We value the company at 12.8x FY23 EPS to arrive at the target of 161," the note said.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Dec 29, 2022 4:56 PM
Share market update: Most active stocks on D-Street today in terms of volume
Share market update: Most active stocks on D-Street today in terms of volume
The NSE Nifty index was trading 100.25 points down at 18022.25
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Dec 29, 2022 3:56 PM
Share market update: Most active stocks of the day in terms of total traded value
Share market update: Most active stocks of the day in terms of total traded value
The NSE Nifty index was trading 113.95 points down at 18008.55
The Economic Times
Like
Comment
Share
Add a comment
Kd Analyst -display-image
Reputation: 2,740  •  Dec 29, 2022 1:54 AM


It has formed a symmetrical triangle pattern.
Closed on support.
Highest OI in call side is at 1020
Highest OI in Put side is at 1000

Sell below: 990
Target: 986, 982
SL: 995

Buy above: 1001
Target: 1005, 1010
SL : 999

Trade as per your own analysis and research.
Market is suprem......read more
Chartbusters - chart - 20667350
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Dec 22, 2022 5:16 PM
Some of the internet businesses could be dark horse of the next year: Pankaj Murarka
Some of the internet businesses could be dark horse of the next year: Pankaj Murarka
Indian companies have a very dominant market share given our low cost manufacturing base in India so I think on a broad basis most of the companies will see a very healthy profit recovery.
The Economic Times
Like
Comment
Share
Add a comment
Dhyey patel-display-image
Reputation: 636  •  Dec 22, 2022 2:33 PM

Intraday trade for 22nd Dec
Buy above ₹1015
Target: ₹1025-1035
*buy only after reconfirmation because market can be very volatile today and we can see some big moves in nifty due to yesterday's fall and today's expire.
Chartbusters - chart - 19738859
2 Likes
1 Comment
Share
Add a comment
Kd Analyst -display-image
Reputation: 2,740  •  Dec 22, 2022 5:25 AM


Buy above 1012 Sell below: 999
SL: 1006 SL: 1005
TGT: 1016,1021 TGT: 994, 990

-> It has given breakout of a range If sustain above 1012 then one can go long.
-> It will change the trend below 999
-> Volume at the time of breakou......read more
Chartbusters - chart - 19738662
Like
1 Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Dec 17, 2022 2:18 AM
FDA's warning letter points to cGMP violations at Halol facility: Sun Pharma
FDA's warning letter points to cGMP violations at Halol facility: Sun Pharma
The US FDA last week listed the Halol facility in Gujarat under import alert with products manufactured at the unit now subject to refusal of admission in the US market.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Dec 16, 2022 4:51 PM
Buy Sun Pharmaceutical Industries, target price Rs 1260:  ICICI Direct
Buy Sun Pharmaceutical Industries, target price Rs 1260: ICICI Direct
Currently, the stock is trading above its mean+1*sigma levels where the brokerage expects it to witness fresh buying interest on dips. The brokerage expect it to cross its life-time highs.
The Economic Times
Like
Comment
Share
Add a comment
Valid CHARTS -display-image
Reputation: 9,023  •  Dec 15, 2022 11:50 PM
1 Like
Comment
Share
Add a comment
Trading Addict-display-image
Reputation: 26,261  •  Dec 14, 2022 3:00 AM

SUNPHARMA for Intraday tomorrow
DATE- 14.12.22
Chartbusters - chart - 18753329
24 Likes
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Dec 12, 2022 4:21 PM
Hot Stocks: Brokerages on Bharat Forge and Sun Pharma; JPMorgan see 28% upside in PNB
Hot Stocks: Brokerages on Bharat Forge and Sun Pharma; JPMorgan see 28% upside in PNB
BofA Securities maintained its buy rating on Sun Pharma with a target of Rs 1,000. Flattish llumya trend and the company is waiting for Winlevi Rx to pick up. Sun Pharma's global specialty revenue growth was 30% in H1FY23, this was largely aided by llumya ramp-up. Regulatory overhang continues.
The Economic Times
Like
Comment
Share
Add a comment
MR Penny-display-image
Reputation: 2,670  •  Dec 11, 2022 3:24 AM

Investment Idea

Advance level
Buy If you got 940
taret 1020
sl 855
Chartbusters - chart - 18463228
3 Likes
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Dec 9, 2022 6:01 PM
Buy Sun Pharmaceutical Industries, target price Rs 1175:  Prabhudas Lilladher
Buy Sun Pharmaceutical Industries, target price Rs 1175: Prabhudas Lilladher
Sun Pharmaceutical Industries, incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 238517.89 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Dec 9, 2022 4:56 PM
Hot Stocks: Global brokerages see 12-15% return in HUL, RIL and Sun Pharma
Hot Stocks: Global brokerages see 12-15% return in HUL, RIL and Sun Pharma
Citigroup maintained its buy rating on Hindustan Unilever with a target price of Rs 3050. The company announced entry into Health and well-being which is a positive sign, the brokerage said.
The Economic Times
Like
Comment
Share
Add a comment
Prathap-display-image
Reputation: 888  •  Dec 9, 2022 1:22 AM

#SUNPHARMA for short term
Bullish Order Block at 935-964 range
Bullish Order Block at 856.80-877 range
SUNPHARMA can touch 1158 levels in short term, try will small stop loss, for stop loss check screenshot levels, if order blocks zone broken exit longs
Chartbusters - chart - 18313734
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Dec 8, 2022 11:18 PM
Sun Pharma clarifies on US FDA import alert on Halol plant; details here
Sun Pharma clarifies on US FDA import alert on Halol plant; details here
Clarifying the effect on the revenue and the revision of future guidance of the company, Sun Pharma stated, "We are not revising our revenue guidance for the current financial year."
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Dec 8, 2022 9:41 PM
Share market update: Most active stocks in today's market in terms of volume
Share market update: Most active stocks in today's market in terms of volume
The NSE Nifty index closed 48.85 points up at 18609.35
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Dec 8, 2022 7:08 PM
Sun Pharma's Halol facility listed under USFDA import alert
Sun Pharma's Halol facility listed under USFDA import alert
The development follows an inspection of the facility by the US Food and Drug Administration (USFDA) from April 26 to May 9, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Dec 8, 2022 4:41 PM
Sun Pharma shares fall over 3% after USFDA action
Sun Pharma shares fall over 3% after USFDA action
Shares of Sun Pharmaceutical on Thursday lost up to 3.5% to hit the day's low at Rs 981.50 in morning trade after the company told stock exchanges that its Halol facility in Gujarat had been placed under 'Import Alert' by USFDA.We now wish to inform you that the Company received a communication from the USFDA stating that the facility has been listed under Import Alert," Sun Pharma said in a regulatory filing.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Dec 8, 2022 4:28 PM
USFDA lists Sun Pharma's Halol facility under 'import alert'
USFDA lists Sun Pharma's Halol facility under 'import alert'
USFDA inspected the company’s Halol facility in Gujarat from April 26 to May 9, 2022
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Dec 8, 2022 4:13 PM
Buy Sun Pharmaceuticals Industries; target of Rs 1300: Sharekhan
Buy Sun Pharmaceuticals Industries; target of Rs 1300: Sharekhan
Sharekhan is bullish on Sun Pharmaceuticals Industries has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated December 07, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Dec 6, 2022 11:31 PM
Are midcaps a good buy in this market? Neeraj Dewan of Quantum Securities answers
Are midcaps a good buy in this market? Neeraj Dewan of Quantum Securities answers
Neeraj Dewan: Yes, definitely. There are still opportunities there. One such sector is the construction and infrastructure sector, where I do not think you are trading at high valuations right now. There are still stocks trading below their average trading multiples, and there is definitely a good order book.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Nov 30, 2022 10:56 PM
Share market update: Most active stocks in today's market in terms of volume
Share market update: Most active stocks in today's market in terms of volume
The NSE Nifty index closed 140.3 points up at 18758.35
The Economic Times
Like
Comment
Share
Add a comment
Kewat Ajay-display-image
Reputation: 1,070  •  Nov 29, 2022 11:23 PM

Chart Analysis for Study Purpose: A breakout could be seen in #SUNPHARMA for tomorrow 30th Nov. We dont see a good volume today in increasing order, so breakout chances are less... but keep an eye... If it cross above 1053 and holds, we could see a good rally in this stock...
Chartbusters - chart - 17330616
Like
1 Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,839  •  Nov 25, 2022 2:46 PM
See value in 2 insurance stocks; no value in Bikaji Foods: Sandip Sabharwal
See value in 2 insurance stocks; no value in Bikaji Foods: Sandip Sabharwal
“There is no value in Bikaji Foods. The entire speculative activity in the market has shifted from the new generation technology stocks where people have lost a lot of money to these newly listed companies. Any long-term investor should just ignore these moves. HDFC Life seems to have value as it has the potential of giving double digit returns over the next one year. ICICI Pru Life got sold out very substantially right from Rs 620-630 odd to Rs 460 in a straight line,”
The Economic Times
Like
Comment
Share
Add a comment
N
Like
Comment
Share
Add a comment
Load More Posts